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Prevention of Ulcer Disease in Goldfish by Means of
Vaccination
PETER A. W. ROBERTSON, DAWN A. AUSTIN, AND BRIAN AUSTIN*
School of Life Sciences, John Muir Building, Heriot-Watt University, Riccarton,
Edinburgh EH14 4AS, Scotland, UK
Abstract.—A vaccine comprising cells of Aeromonas bestiarum grown in tryptic soy broth and
atypical A. salmonicida cells produced in iron-limited and iron-supplemented media protected
goldfish Carassius auratus when administered by immersion (dosage ø 5 3 107 cells/mL for 60
s) followed after 28 d by an oral booster (dosage 5 5 3 107 cells/g of feed), which was fed for
7 d so that each fish received about 1 g of vaccine-containing feed. After challenge by intramuscular
injection of a virulent culture of atypical A. salmonicida, the relative percent survival (RPS) was
more than 90%. The approach was more successful than using a commercial furunculosis vaccine
with or without supplementation with A. bestiarum or atypical A. salmonicida cells. Moreover, a
smooth derivative of the virulent rough culture of atypical A. salmonicida was less effective as a
vaccine candidate, yielding an RPS of only 65%. Low antibody titers of 1:39–1:396 were found
in the vaccinated fish. The vaccinated fish had a significantly higher proportion of dead head kidney
macrophages (10.9 6 3.5%; P 5 0.0149) than did the controls (6.8 6 3.1%). However, differences
in the number of erythrocytes and leukocytes, the level of phagocytic and lysozyme activities,
and the proportion of lymphocytes, monocytes, and polymorphonuclear cells were not statistically
significant between the two groups.
The origin of vaccine development for furun-
culosis may be traced to the work of Duff (1942),
who used an orally administered chloroform-in-
activated suspension of whole cells and success-
fully protected cutthroat trout Oncorhynchus clark-
ii. Subsequent work rarely equaled or surpassed
this original study (see Austin and Austin 1999).
Goldfish Carassius auratus may become infected
with so-called atypical Aeromonas salmonicida,
which leads to the development of unsightly ulcers
(Austin and Austin 1999). Often, the ulcers are
populated with mixed cultures in which motile
aeromonads, typically identified as A. hydrophila,
are common (Austin and Austin 1999). There is a
lack of evidence of synergism between bacterial
groups leading to exacerbated disease, and these
motile aeromonads may be secondary invaders of
ulcerated tissue (Austin and Austin 1999). Previ-
ous work to develop vaccines for the control of
ulcer disease of cyprinids has met with mixed suc-
cess (e.g., Kozinska and Guz 2004), often because
of the lack of a reproducible challenge method
(Austin and Austin 1999). With the current success
in salmonids of formalin-inactivated A. salmoni-
cida preparations (e.g., Durbin et al. 1999), we
considered it timely to reexamine the potential of
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vaccines for controlling ulcer disease in ornamen-
tal fish.
Methods
Source of bacterial cultures.—One hundred
eighty-three live, ulcerated ornamental fish—gold-
fish and koi carp Cyprinus carpio—were received
from wholesale and retail outlets in England. The
fish were killed by overdose with anesthetic (MS-
222; Sigma, Basingstoke, UK) and, using flame-
sterilized scalpels, we cut into the muscle leading
away from the ulcers. Loopfuls of material were
spread over the surface of 5% (volume basis [v/
v]) horse blood in nutrient agar, 5% (v/v) sheep
blood in nutrient agar, and tryptic soy agar (TSA;
all materials from Oxoid, Basingstoke, UK) and
incubated room temperature (18–208C) for 7 d.
Plates with dense growth representing no more
than two dominant colony types were examined
further, and pure cultures were obtained by streak-
ing and restreaking on fresh media. Thus, 42 pure
cultures were obtained, which we equated with A.
bestiarum (7 cultures) and A. salmonicida (35 cul-
tures) after comparing with published character-
istics (Ali et al. 1996; Austin et al. 1998). In sub-
sequent vaccination experiments, we used three
cultures from goldfish, ORN2 (5 A. bestiarum) and
ORN6 and ORN6a (5 brown pigmented, autoag-
glutinating, rough [A-layer1] atypical A. salmon-
icida), which had been determined to be virulent
in separate infectivity experiments. Stock cultures
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204 ROBERTSON ET AL.
TABLE 1.—Vaccine formulations evaluated in a study of ulcer disease in goldfish. The abbreviations ORN2 and ORN6
refer to cultures of Acromonas bestiarum and A. salmonicida; TSB refers to tryptic soy broth.
Vaccine Immersion Oral Oral boost
Furovac 5 1 1
Furovac 5 supplemented with iron-limited preparations of ORN2 and ORN6 1 1
Furovac 5 supplemented with iron-limited and iron-supplemented preparations of
ORN2 and ORN6 1 1
Iron-restricted preparation of ORN6 1
Iron-supplemented preparation of ORN6 1
Iron-limited preparation of ORN6 and cells of ORN2 grown in TSB 1 1
Iron-supplemented preparation of ORN6 and cells of ORN2 grown in TSB 1 1
Iron-limited and iron-supplemented preparation of ORN2 and ORN6 1 1
Iron-limited and iron-supplemented preparation of ORN6 and cells of ORN2 grown
in TSB 1 1 1
Cells of ORN2 and ORN6 grown in TSB 1 1
Iron-limited and iron-supplemented preparation of a smooth culture of ORN6 and
cells of ORN2 grown in TSB 1 1
were stored at2708C either in tryptic soy broth
(TSB; Oxoid) containing 15% (v/v) glycerol (Sigma)
or as freeze-dried preparations. Routinely, the cul-
tures were maintained on TSA plates and slopes at
room temperature with subculturing every 7–14 d.
Fish stocks.—Stocks of goldfish approximately
6 cm long were obtained from commercial sites in
England and were maintained in aerated, recir-
culating freshwater at 178C. We examined their
health status (Austin and Austin 1989) and used
only stocks deemed to be healthy and, in particular,
free of ulceration in subsequent experiments.
Vaccines.—A commercial vaccine against A.
salmonicida (Furovac 5; Schering Plough Aqua-
culture Division, Saffron Walden, UK) was used
with and without supplementation with formalin-
inactivated (to 0.2% [v/v] with incubation at room
temperature for 7 d) cells of A. bestiarum ORN2,
atypical A. salmonicida ORN6, or both. Additional
preparations were based exclusively on the labo-
ratory-produced inactivated cell suspensions, and
the formulated products contained equal numbers
of cells of each component (Table 1). The cultures
were grown for 48 h at room temperature in TSB
with or without 0.1 mM dipyridyl (Sigma) to in-
duce iron-deficient conditions and the production
of iron-regulated outer membrane proteins
(IROMPs) (Durbin et al. 1999) or with 0.1 mM
ferric chloride (Sigma) for iron supplementation.
Additionally, ORN6 was repeatedly subcultured
every 7 d with incubation at 308C to induce the
development of nonautoagglutinating smooth cul-
tures (Austin and Austin 1999), which we used to
produce vaccines. After inactivation with forma-
lin, the cultures were checked for inactivation by
inoculating 1.0-mL volumes into 9.0 mL of TSB
and incubating at room temperature for 7 d. Then,
0.1-mL volumes of this incubated material were
spread over the surface of triplicate plates of TSA
and further incubated for up to 7 d at room tem-
perature. The absence of growth was used as an
indication of inactivation. The formalin-treated
cultures were stored in the original inactivated
growth medium at 48C until required.
Vaccination regimes.—Groups of 100 goldfish
were vaccinated by immersion or orally, and 28 d
after the initial procedure were treated with or
without immersion or oral booster doses. For im-
mersion vaccination, we diluted the stock vaccine
in tank water to about 5 3 107 cells/mL, as de-
termined by reading a sample on a hemocytometer
slide (Improved Neubauer type; Merck, Lutter-
worth, UK) at a magnification of 4003 on an Ax-
iophot microscope (Carl Zeiss, Welwyn Garden
City, UK). The fish were immersed in this diluted
vaccine for 60 s before being returned to the hold-
ing tanks. For oral vaccination, we mixed the vac-
cine with an equal volume of oralizer (Schering
Plough Aquaculture; International Patent WO 92/
06599) that contained fish oil and emulsifying
agent. We emulsified the mixture at high-shear
forces for 20 min in a Silverson (Waterside, Ches-
ham, UK) homogenizer, and then mixed this emul-
sion with commercial pelleted feed to achieve a
dose equivalent to 5 3 107 cells/g of feed. This
preparation was fed on demand to the fish, three
times daily for 7 d, such that each fish received
about 1.0 g of feed in total. Additional feeding on
demand was with the same commercial pelleted
feed, minus the added emulsion. Each vaccination
procedure was carried out once for each set of
experiments, but over the course of the work, the
vaccines were evaluated four times.
Challenge experiments.—The fish were chal-
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205VACCINE FOR ULCER DISEASE
lenged 28 d after initial vaccination or booster with
atypical A. salmonicida ORN6a by intramuscular
injection of this organism at 2 3 102 cells/fish.
Preliminary experiments revealed that this was the
equivalent of an LD80 dose (the dose at which
80% of infected fish died), with an outcome of
ulceration and mortality. Thus, we grew the in-
fectious culture overnight at room temperature in
TSB, centrifuged it (4000 3 g at 48C for 15 min),
washed it twice, resuspended it in 0.9% (w/v) sa-
line, and determined the cell count of the culture
by viewing on a hemocytometer slide (Improved
Neubauer Type) at a magnification of 4003 on a
Carl Zeiss Axiophot microscope. The fish were
examined daily for 21 d, and the number of mor-
talities recorded and used to calculate the relative
percent survival (RPS; Amend 1981). We exam-
ined dead and moribund fish microbiologically to
confirm the presence of atypical A. salmonicida
(Austin et al. 1998).
Statistics.—Quantitative data were examined by
a range of statistical methods, including the cal-
culation of standard deviations, Student’s t-test,
and the Mann–Whitney test (Steele and Torrie
1981), contained on the INSTAT 2.01 for Mac-
intosh software (GraphPad Software, San Diego,
California). We used the parametric Student’s t-
test to examine all immunology data.Where the
data did not follow Gaussian distribution patterns,
we also used the nonparametric Mann–Whitney
test to determine statistical significance.
Immunology.—The methods used to examine
changes in immunological parameters after vac-
cination have been described elsewhere (Irianto
and Austin 2002). In brief, blood was collected
from freshly killed fish (10 fish per group) by ve-
nipuncture, and then diluted 10-fold and 100-fold
in phosphate-buffered saline at pH 7.2 (PBS; Ox-
oid). We examine the diluted sample microscopi-
cally using a hemocytometer slide (Improved Neu-
bauer Type) to determine the number of leukocytes
and erythrocytes. We also examined blood films
to determine the relative proportion of leukocytes,
that is, of polymorphonuclear granulocytes, lym-
phocytes, and monocytes. The remainder of the
blood was transferred to evacuated collection
tubes containing clot-activating gel (Vacuettes;
Greiner, Gloucester, UK), and allowed to clot by
incubation at room temperature for 1 h, and stored
overnight at 48C. The serum obtained was then
removed and stored at2708C until required.
Lysozyme activity in serum samples was deter-
mined by the reduction in optical density at 570
nm of a suspension of Micrococcus luteus (for-
merly M. lysodeikticus) obtained from the National
Collection of Industrial and Marine Bacteria
(NCIMB, Aberdeen, UK; 9278) as described by
Irianto and Austin (2002). We also analyzed the
serum samples with an enzyme-linked immuno-
sorbent assay (ELISA) to determine the presence
and titer of antibodies to atypical A. salmonicida
ORN6 (Durbin et al. 1999).
From the same fish we obtained the kidneys and
used them to determine the relative proportion of
dead and live macrophages and macrophage
phagocytic activity (Irianto and Austin 2002).
Results
Vaccination
The results revealed that the commercial furun-
culosis vaccine (Furovac 5) administered by im-
mersion with or without an oral booster did not
protect goldfish against mortalities when chal-
lenged with atypical A. salmonicida; the cumula-
tive mortalities over 21 d corresponding to those
of the controls (experiment 1; Table 2). Moreover,
supplementing this vaccine with formalin-inacti-
vated cells of ORN2 and ORN6, grown in con-
ditions of iron-limitation, did not improve protec-
tion (experiment 2; Table 2). Indeed, for fish im-
mersed in the iron-limited and iron-supplemented
preparations, the cumulative mortalities exceeded
those of the controls (experiment 2; Table 2). Yet
supplementing the commercial vaccine with iron-
limited and iron-supplemented preparations im-
proved the benefit of immersion vaccination fol-
lowed by an oral booster after 28 d (Table 2), the
cumulative mortalities being less than those of the
controls (experiment 2; Table 2). Consequently, we
focused solely on vaccines based exclusively
around isolates recovered from ornamental fish.
Using formalin-treated cells of atypical A. sal-
monicida ORN6 that had been grown in either iron-
limited or iron-supplemented conditions was not
successful when administered only by immersion,
in comparison with the controls (experiment 3;
Table 2). Similarly, a mixture of A. bestiarum
ORN2 and atypical A. salmonicida ORN6 cells
prepared in iron-limited and iron-supplemented
conditions was not effective when administered to
goldfish solely by immersion (experiment 4; RPS
5 1%; Table 2). But the administration of an oral
booster to goldfish after immersion vaccination
substantially improved protection (experiment 4;
RPS 5 81%; Table 2). Here, the cumulative mor-
tality among the vaccinated fish was only16%,
compared with 84% total mortalities in the con-
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206 ROBERTSON ET AL.
TABLE 2.—Effect of vaccination on survival of groups of 100 goldfish following challenge with atypical A. salmon-
icida (ORN6a). The abbreviation RPS stands for relative percent survival and was calculated according to Amend
(1981). See Table 1 for other abbreviations. A plus sign denotes a positive effect, a minus sign no effect.
Exper-
iment
Vaccine
Furovac 5
Iron limited
ORN2 ORN6
Iron supplemented
ORN2 ORN6
TSB
ORN2 ORN6
Vaccination regime
Immersion
Oral
boost
Mortalities
21 d after
challenge (%) RPS
1 1 2 2 2 2 2 2 1 2 95 3
1 2 2 2 2 2 2 1 1 98 3
2 2 2 2 2 2 2 2 2 98 (control)
2 1 1 1 2 2 2 2 1 2 53 0
1 1 1 2 2 2 2 1 1 37 0
1 1 1 1 1 2 2 1 2 52 0
1 1 1 1 1 2 2 1 1 25 26
2 2 2 2 2 2 2 2 2 34 (control)
3 2 2 1 2 2 2 2 1 2 94 2
2 2 2 2 1 2 2 1 2 86 9
2 2 2 2 2 2 2 2 2 95 (control)
4 2 1 1 1 1 2 2 1 2 85 1
2 1 1 1 1 2 2 1 1 16 81
2 2 2 2 2 2 2 2 2 84 (control)
5 2 1 1 1 1 2 2 1 2 37 62
2 2 1 2 1 1 2 1 2 9 91
2 2 1 2 1 1 2 1 1 7 93
2 2 2 2 2 2 2 2 2 98 (control)
6 2 2 2 2 2 1 1 1 2 48 51
2 2 1 2 2 1 1 1 1 65 27
2 2 1 2 1 1 2 1 2 69 23
2 2 1 2 1 1 2 1 1 28 69
2 2 2 2 2 2 2 2 2 89 (control)
7 2 2 1 2 1 1 2 1 1 4 96
2 2 2 2 2 2 2 2 2 99 (control)
8 2 2 1a 2 1a 1 2 1 1 35 65
2 2 1 2 1 1 2 1 1 7 93
2 2 2 2 2 2 2 2 2 99 (control)
a Smooth isolate.
trols after 21 d (experiment 4; Table 2). Replacing
the iron-limited or iron-supplemented ORN2 com-
ponent with cells grown in TSB was generally su-
perior; treatment with this preparation after im-
mersion vaccination and challenge improved the
protection of goldfish in that the RPS increased
from 62% to 91% (experiment 5; Table 2).
The use of ORN2 and ORN6 grown only in TSB
gave only moderate levels of protection when ad-
ministered by immersion with or without an oral
booster. When immersion only was used, an RPS
of 51% was recorded (experiment 6; Table 2). In
a separate experiment, iron-limited and iron-sup-
plemented cells of ORN6 (used separately and in
combination) plus cells of ORN2 grown in TSB
were used to vaccinate fish by immersion followed
by an oral booster with the homologous oralized
product. After challenge, 98 unvaccinated controls
died compared with 4 in the group that received
the iron-limited and iron-supplemented cells of
ORN6 (RPS 5 96%), 37 of the group that received
iron-limited cells of ORN6 by immersion and an
oral booster (RPS 5 62%), and 44 of the group
that received iron-supplemented cells of ORN6 by
immersion and an oral booster (RPS 5 55%),
Consistently over four replicate experiments, we
found that the use of formalin-inactivated cells of
atypical A. salmonicida ORN6 grown in iron-lim-
ited and iron-supplemented conditions together
with A. bestiarum grown in TSB when applied by
immersion with an oral booster provided excellent
protection (Table 2). In one experiment, an RPS
of 96% was achieved (experiment 7; Table 2); that
is, only 4% of the vaccinated fish died, compared
with 99% of the controls. Moreover, the surviving
vaccinated fish were completely devoid of ulcers.
Parallel results were obtained in replicates, with
RPS values ranging from 96% to 99% (experiment
7–8). Application of the vaccine solely by the oral
route was less successful in that a primary (oral)
vaccination led to 68 mortalities (RPS 5 12%),
whereas an oral booster was only marginally bet-
ter, with 58 mortalities (RPS 5 25%). In compar-
ison, only 6 mortalities (RPS 5 92%) occurred
when the vaccine was administered by immersion
and an oral booster, but the unvaccinated controls
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207VACCINE FOR ULCER DISEASE
TABLE 3.—Numbers of erythrocytes and leucocytes and phagocytic and lysozyme activity (6 SDs) in goldfish (group
size 5 50; average length 5 6 cm) after administering iron-limited and iron-supplemented preparations of ORN6 and
cells of ORN2 grown in TSB by immersion followed by an oral booster; see Table 1 for abbreviations. The fish were
examined on the same day as challenge, 28 d after feeding the oral booster. P-values are given in parentheses; differences
are considered statistically significant when P , 0.05.
Group
Erythrocytes
(3 108/mL)
Leucocytes
(3 107/mL) Dead macrophages (%) Phagocytic activity
Lysozyme activity
(units)
Vaccinates 7.4 6 2.6 (0.9283) 1.3 6 1.9 (0.7302) 10.9 6 3.5 (0.0149) 48.9 6 8.7 (0.2774) 28.7 6 24.1 (0.3843)
Control 7.6 6 4.6 0.4 6 0.2 6.8 6 3.1 53.3 6 8.9 15.2 6 17.0
TABLE 4.—Proportion (%) of lymphocytes, monocytes, and polymorphonuclear granulocytes in goldfish blood (av-
erage fish length 5 6 cm) after administering iron-limited and iron-supplemented preparations of ORN6 and cells of
ORN2 grown in TSB by immersion, followed by an oral booster; see Table 1 for abbreviations. The fish were examined
on the same day as challenge, 28 d after feeding the oral booster. P-values are given in parentheses; differences are
considered statistically significant when P , 0.05.
Group Lymphocytes Monocytes
Polymorphonuclear
granulocytes
Vaccinates 59.2 6 10.1 (0.5841) 8.4 6 2.6 (0.3154) 32.4 6 8.9 (0.7096)
Control 62.6 6 15.4 7.5 6 5.0 30.4 6 13.0
had 77 mortalities. Interestingly, a smooth deriv-
ative of ORN6 was less successful than the original
rough isolate, yielding RPS values of 65% and
93%, respectively (experiment 8; Table 2). The use
of formalin-inactivated cells of atypical A. sal-
monicida ORN6 grown in iron-limited and iron-
supplemented conditions, together with A. bestia-
rum grown in TSB applied orally with or without
an oral booster, was less successful than when ap-
plied by immersion followed by an oral booster
(experiment 9; Table 2).
Immunology
The following data were obtained by using for-
malin-inactivated cells of atypical A. salmonicida
ORN6 grown in iron-limited and iron-supple-
mented conditions and A. bestiarum grown in TSB,
when applied by immersion with an oral booster.
Thus by ELISA, serum antibodies to atypical A.
salmonicida were detected by the time of challenge
in vaccinated fish. Low antibody titers of 1:19–1:
99 were consistently recorded among the unvac-
cinated control goldfish. Titers of 1:39–1:396 were
found in the fish that had been vaccinated by im-
mersion (followed by an oral booster) with iron-
limited and iron-supplemented preparations of
atypical A. salmonicida ORN6, or with cells of A.
bestiarum ORN2 grown in TSB. In contrast, use
of Furovac 5 resulted in antibody titers among the
vaccinated fish of 1:4–1:99, that is, similar to those
of the unvaccinated controls.
Tables 3 and 4 present data for the numbers of
erythrocytes and leukocytes; the proportion of
phagocytosing macrophages; the relative propor-
tions of lymphocytes, monocytes, and polymor-
phonuclear cells; and the lysozyme activity. Gen-
erally, immersion vaccination and oral boosting
with iron-restricted and iron-supplemented cells of
atypical A. salmonicida ORN6 and the preparation
of A. bestiarum ORN2 in TSB, goldfish demon-
strated more leukocytes, (1.3 6 1.9) 3 107/mL,
than did the controls, (0.4 6 0.2) 3 107/mL (Table
3), although these data were not regarded as sta-
tistically significant (P 5 0.7302, Mann–Whitley
test). Similarly, a higher proportion of dead mac-
rophages, which did not appear to be necrotic or
apoptotic, were recorded for vaccinated fish (10.9
6 3.5%) than for the controls (6.8 6 3.1%), a
difference that was statistically significant (P 5
0.0149, Student’s t-test). Incidentally, all the kid-
neys appeared to be in good condition, devoid of
any visual signs of damage or disease. The number
of erythrocytes was similar between vaccinates
and controls (Table 3), with differences that were
not statistically significant (P 5 0.9283, Student’s
t-test). Furthermore, the levels of phagocytic mac-
rophages (P 5 0.2774), lysozyme activity (P 5
0.3843), and the proportion of lymphocytes (P 5
0.5841), monocytes (P 5 0.3154), and polymor-
phonuclear granulocytes (P 5 0.7096) in vacci-
nated and control fish were not regarded as statis-
tically different (Table 3 and 4).
Discussion
The data reveal that a vaccination strategy may
be used successfully to combat mortalities result-
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208 ROBERTSON ET AL.
ing from infection with atypical A. salmonicida in
goldfish. As such, our findings lend support to the
previously stated view that vaccines containing
atypical A. salmonicida cells may be beneficial
when confronting disease attributed to these
strains, insofar as commercial products developed
with typical strains for salmonids are generally not
effective (Lund et al. 2002). Certainly, there are
indications that vaccines prepared with atypical
isolates of A. salmonicida are successful; for ex-
ample, the RPS of about 90% achieved in Atlantic
halibut and spotted wolffish (Ingilae et al. 2000)
is compatible with that achieved for ornamental
fish in this study. Thus, there are parallels with the
perceived benefits of autogenous vaccines (Gud-
mundsdo´ttir et al. 2003), in this case containing
atypical A. salmonicida from the actual host. Sim-
ilar to previous studies, our data point to the value
of virulent (i.e., rough) cells of A. salmonicida for
conferring greater protection than the smooth var-
iant (Lund et al. 2003). Indeed, the A-layer of an
atypical isolate of A. salmonicida has been deter-
mined to be immunogenic for goldfish (Sinyakov
et al. 2001). However, the most successful vac-
cination regime involved cells of atypical A. sal-
monicida grown in conditions of iron restriction
and iron supplementation together with cells of A.
bestiarum grown on standard bacteriological me-
dium (e.g., TSB) administered by an initial im-
mersion followed by an oral booster. The approach
is in agreement with previous studies with sal-
monids, when protection was enhanced after ad-
ministration of an oral booster (Thorburn and Jans-
son 1988; Midtlyng et al. 1996). Moreover, Arijo
et al. (2003) reported significantly increased pro-
tection in sea bream after booster vaccination,
which they attributed to increased levels of anti-
body against bacterial lipopolysaccharides. Fur-
thermore, the value of oral vaccination for stim-
ulation of specific antibody production and innate
cellular immunity has been well recognized (e.g.,
Durbin et al. 1999).
Aeromonas bestiarum, a recent addition to the
range of fish pathogens (Kozinska and Guz 2004),
may be beneficial as a component of the vaccine
because of a possible immunostimulatory role,
such as by means of lipopolysaccharide (Logho-
thetis and Austin 1996) and the presence of shared
antigens with other bacterial species (Swain et al.
2003). Indeed, polyvalent vaccines have shown
greater protection against A. salmonicida infec-
tions in Atlantic salmon than have monovalent
preparations (Hoel et al. 1998; Lund et al. 2003).
The nature of the protection may well involve
antibody production (Bricknell et al. 1999) and
stimulation of innate immunity (Irianto and Austin
2002). Other workers have pointed to a greater
correlation between protection and antibody titer
(Bricknell et al. 1999) than we inferred in this
investigation. However, any specific antibody re-
sponse may take many weeks to develop and lead
to protection, whereas innate mechanisms are ac-
tivated within days (Ellis 2001). Thus, innate de-
fense mechanisms might well be more important
than previously realized. In this study, we found
a statistically significant difference between vac-
cinated fish and controls regarding the number of
head kidney macrophages absorbing trypan blue.
Furthermore, although not statistically significant,
the vaccinated fish had an increase in the number
of leukocytes compared with the controls, which
agrees with earlier work on probiotics (Irianto and
Austin 2003).
In conclusion, the use of a polyvalent vaccine
by immersion and an oral booster can protect gold-
fish against ulcer disease. However, it remains for
further work to determine the precise duration of
protection.
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